Investment
Features
FeesSafety
Academy
More
Pluang+

CoreWeave stock dips to $85 amid strong AI growth but high debt raises caution for investors.

Market News
01 Sep 2026
24/7 Wall Street
View Source
Bullish
pluang ai news

CoreWeave's stock has fallen from its May peak to around $85, reflecting concerns over its heavy debt despite strong AI-focused revenue growth. The company reported $2.58 billion in Q2 revenue, doubling year-over-year, and holds a $104 billion revenue backlog. While the firm's specialized AI cloud infrastructure offers cost advantages and margin expansion is expected by Q4, its large capital expenditures and $72 billion liabilities pose risks. Investors see potential upside if CoreWeave can manage debt and scale power capacity, but caution remains due to market and operational uncertainties.

More News

Lands' End Q2 revenue beats estimates, EPS slightly misses; balance sheet improves but liquidity cautious.

Lands' End Q2 revenue beats estimates, EPS slightly misses; balance sheet improves but liquidity cautious.

Lands' End reported Q2 fiscal results with revenue rising 2.7% to $302 million, beating analyst expectations, while adjusted EPS missed slightly at $0.09 versus $0.10 forecast. The company improved profitability from a year ago, turning an adjusted l...

Company Fundamentals
Neutral
1 hour ago
Planet Labs Q2 earnings expected to improve losses by 33%, with strong backlog growth signaling future potential.

Planet Labs Q2 earnings expected to improve losses by 33%, with strong backlog growth signaling future potential.

Planet Labs is set to report its Q2 earnings, with analysts expecting a loss of $0.02 per share, a 33.3% improvement from last year. Revenue is estimated at $104.12 million. Despite a significant stock decline, trading 27% below its 200-day average, ...

Company Fundamentals
Neutral
1 hour ago
CVS Health raises revenue forecast after strong Q2, analysts see 21-28% stock upside.

CVS Health raises revenue forecast after strong Q2, analysts see 21-28% stock upside.

CVS Health reported a 7.3% revenue increase in Q2 to $106.1 billion and raised its full-year revenue forecast to at least $414 billion, alongside improved earnings per share guidance. Despite UBS lowering its price target to $118, analysts like Jeffe...

Analyst Insights
Bullish
1 hour ago
Zscaler earnings preview focuses on AI security growth and cautious fiscal 2027 guidance.

Zscaler earnings preview focuses on AI security growth and cautious fiscal 2027 guidance.

Zscaler is set to report earnings with an expected EPS of $1.09 and revenue near $877 million, reflecting about 22% growth year-over-year. Investors are closely watching the company's fiscal 2027 guidance after a previous outlook caused a sharp 31.52...

Company Fundamentals
Bullish
2 hours ago
Canaccord lowers Gold.com's price target despite strong FY26 growth, citing weak Q4 results.

Canaccord lowers Gold.com's price target despite strong FY26 growth, citing weak Q4 results.

Canaccord Genuity maintained a Buy rating on Gold.com but reduced its price target from $70 to $65 due to weaker-than-expected fourth-quarter results. Gold.com reported a strong fiscal 2026 with revenue up 132% to $25.51 billion and net income rising...

Analyst Insights
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App